|
NFAT5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58478999999767E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.602390E-04 |
| Normal-vs-Stage2 |
7.973900E-04 |
| Normal-vs-Stage3 |
2.42440000000066E-05 |
| Normal-vs-Stage4 |
4.91800000002041E-06 |
| Stage1-vs-Stage2 |
4.477400E-01 |
| Stage1-vs-Stage3 |
2.117400E-01 |
| Stage1-vs-Stage4 |
7.713700E-02 |
| Stage2-vs-Stage3 |
8.877800E-01 |
| Stage2-vs-Stage4 |
4.487400E-01 |
| Stage3-vs-Stage4 |
4.591400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69606999999017E-05 |
| Normal-vs-AfricanAmerican |
7.663700E-02 |
| Normal-vs-Asian |
7.280500E-03 |
| Caucasian-vs-AfricanAmerican |
3.602200E-01 |
| Caucasian-vs-Asian |
4.200400E-01 |
| AfricanAmerican-vs-Asian |
7.865600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.12030000001917E-06 |
| Normal-vs-Female |
6.23159999999512E-05 |
| Male-vs-Female |
3.417400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.598900E-04 |
| Normal-vs-Age(41-60Yrs) |
2.024100E-04 |
| Normal-vs-Age(61-80Yrs) |
5.19850000046951E-07 |
| Normal-vs-Age(81-100Yrs) |
1.943560E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.580800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.457840E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.028200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.777500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.021900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.767800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.996600E-03 |
| Classical-VS-Follicular |
4.049500E-04 |
| Classical-VS-Other |
3.193200E-01 |
| Classical-VS-Normal |
1.424090E-03 |
| Tall-VS-Follicular |
8.452800E-01 |
| Tall-VS-Other |
8.926200E-01 |
| Tall-VS-Normal |
1.82004000000013E-05 |
| Follicular-VS-Other |
8.486800E-01 |
| Follicular-VS-Normal |
7.42809999954019E-07 |
| Other-VS-Normal |
3.296200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.99849999999091E-06 |
| Normal-vs-N1 |
2.001900E-03 |
| N0-vs-N1 |
6.083600E-01 |
|
|
